ORIGINAL PAPER
The role of ultrasonography in monitoring long-standing rheumatoid arthritis: a pilot study
More details
Hide details
Submission date: 2017-07-17
Final revision date: 2017-08-17
Acceptance date: 2017-08-19
Online publication date: 2017-08-31
Publication date: 2017-08-31
Reumatologia 2017;55(4):177-182
KEYWORDS
TOPICS
ABSTRACT
Objective: Rheumatoid arthritis (RA) is a condition that poses many diagnostic problems. As a result, it is often diagnosed too late, which makes effective treatment more difficult. The course of the disease is chronic, and it causes irreversible changes in the musculoskeletal system, as well as bone destruction, and this in turn impairs the proper monitoring of the treatment. Therefore, in order to assess the treatment’s efficacy, as well as a clinical examination of the patient and laboratory tests, diagnostic imaging is being used more frequently in routine practice. The aim of this paper is to assess the usefulness of power Doppler ultrasonography in the assessment of MCP joints in patients with chronic RA (LSRA), in comparison with DAS28, X-ray, and MRI.
Material and methods: The study involved 26 patients with LSRA, treated with biologics. It lasted for a year. At the moment of enrolment, the condition had lasted for a minimum of 5 years, and DAS28 was > 5.1. The patients had visits every three months. During every visit, a PDUS test was performed and the DAS28 was determined. In the first and last month of the study the patients underwent X-ray and MRI tests.
Results: At the end of the study, the DAS28 of 26 (100%) patients was lower or equal to 3.2. Based on PDUS and MRI tests, no synovitis was found in 21 (81%) and 18 (69%) patients, respectively. According to the MRI results, radiological changes progressed in 5 (19%) of them. All patients who showed progress of radiological changes also had visible synovitis during their PDUS test.
Conclusions: PDUS in patients with LSRA can be helpful in selecting patients, who are likely to develop a progression of radiological changes.
REFERENCES (20)
1.
Migliore A, Bizzi E, Petrella L, et al. The challenge of treating early-stage rheumatoid arthritis: the contribution of mixed treatment comparison to choosing appropriate biologic agents. BioDrugs 2016; 30: 105-115.
2.
van Nies JA, Tsonaka R, Gaujoux-Viala C, et al. Evaluating relationships between symptom duration and persistence of rheumatoid arthritis: does a window of opportunity exist? Results on the Leiden early arthritis clinic and ESPOIR cohorts. Ann Rheum Dis 2015; 74: 806-812.
3.
Lukas C, Combe B, Ravaud P, et al. Favorable effect of very early disease-modifying antirheumatic drug treatment on radiographic progression in early inflammatory arthritis: data from the Étude et Suivi des Polyarthrites IndifféRenciées récentes (study and followup of early undifferentiated polyarthritis). Arthritis Rheum 2011; 63: 1804-1811.
4.
Smolen JS, Landewé R, Bijlsma J, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update. Ann Rheum Dis 2017; 76: 960-977.
5.
Szkudlarek M, Klarlund M, Narvestad E, et al. Ultrasonography of the metacarpophalangeal and proximal interphalangeal joints in rheumatoid arthritis: a comparison with magnetic resonance imaging, conventional radiography and clinical examination. Arthritis Res Ther 2006; 8: R52.
6.
Sudoł-Szopińska I, Mróz J, Ostrowska M, et al. Magnetic resonance imaging in inflammatory rheumatoid diseases. Reumatologia 2016; 54: 170-176.
7.
Mathew AJ, Danda D, Conaghan PG. MRI and ultrasound in rheumatoid arthritis. Curr Opin Rheumatol 2016; 28: 323-329.
8.
Wakefield RJ, Gibbon WW, Conaghan PG, et al. The value of sonography in the detection of bone erosions in patients with rheumatoid arthritis: a comparison with conventional radiography. Arthritis Rheum 2000; 43: 2762-2770.
9.
Ji L, Deng X, Geng Y, et al. The additional benefit of ultrasonography to 2010 ACR/EULAR classification criteria when diagnosing rheumatoid arthritis in the absence of anti-cyclic citrullinated peptide antibodies. Clin Rheumatol 2017; 36: 261-267.
10.
Horton SC, Tan AL, Wakefield RJ, et al. Ultrasound-detectable grey scale synovitis predicts future fulfilment of the 2010 ACR/EULAR RA classification criteria in patients with new-onset undifferentiated arthritis. RMD Open 2017; 3: e000394.
11.
Naredo E, Wakefield RJ, Iagnocco A, et al. The OMERACT ultrasound task force--status and perspectives. J Rheumatol 2011; 38: 2063-2067.
12.
Fiocco U, Ferro F, Vezzù M, et al. Rheumatoid and psoriatic knee synovitis: clinical, grey scale, and power Doppler ultrasound assessment of the response to etanercept. Ann Rheum Dis 2005; 64: 899-905.
13.
Aletaha D, Smolen J. The Simplified Disease Activity Index (SDAI) and the Clinical Disease Activity Index (CDAI): a review of their usefulness and validity in rheumatoid arthritis. Clin Exp Rheumatol 2005; 23: 100-108.
14.
Dejaco C1, Duftner C, Wipfler-Freissmuth E, et al. Ultrasound-defined remission and active disease in rheumatoid arthritis: association with clinical and serologic parameters. Semin Arthritis Rheum 2012; 41: 761-767.
15.
Kirwan JR. Links between radiological change, disability, and pathology in rheumatoid arthritis. J Rheumatol. 2001; 28: 881-886.
16.
Ogishima H, Tsuboi H, Umeda N, et al. Analysis of subclinical synovitis detected by ultrasonography and low-field magnetic resonance imaging in patients with rheumatoid arthritis. Mod Rheumatol 2014; 24: 60-68.
17.
Grassi W, Gaywood I, Pande I, et al. From DAS 28 to SAS 1. Clin Exp Rheumatol 2012; 30: 649-651.
18.
Dale J, Stirling A, Zhang R, et al. Targeting ultrasound remission in early rheumatoid arthritis: the results of the TaSER study, a randomised clinical trial. Ann Rheum Dis 2016; 75: 1043-1050.
19.
Li W, Liu F, Zhu J, et al. Superb Micro-Vascular Imaging improving inflammatory flow blood sensitivity in patients with rheumatoid arthritis. Int J Clin Exp Med 2016; 9: 19930-19934.
20.
Peluso G, Michelutti A, Bosello S, et al. Clinical and ultrasonographic remission determines different chances of relapse in early and long standing rheumatoid arthritis. Ann Rheum Dis 2011; 70: 172-175.
Copyright: © Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji w Warszawie. This is an Open Access journal, all articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (
https://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.